 The target sample will be 20 caregiver-patient dyads. Using a randomized controlled, prospective design, potentially eligible participants will be identified at the time of initial consultation see Figure 1. Outcomes will be assessed at baseline, post-intervention 3 months post-randomization, 6 months post-randomization, and every 4 months up to 2-years in the event that the patient dies. 